Charles Schwab Investment Management Inc. Increases Stake in agilon health, inc. (NYSE:AGL)

Charles Schwab Investment Management Inc. lifted its position in agilon health, inc. (NYSE:AGL - Free Report) by 49.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,541,549 shares of the company's stock after acquiring an additional 1,498,524 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.10% of agilon health worth $8,629,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Oak Thistle LLC purchased a new stake in shares of agilon health during the fourth quarter valued at approximately $25,000. Ieq Capital LLC bought a new stake in shares of agilon health during the 4th quarter worth $26,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of agilon health in the 3rd quarter worth about $28,000. First Citizens Bank & Trust Co. bought a new position in agilon health during the fourth quarter valued at about $46,000. Finally, Pines Wealth Management LLC purchased a new stake in agilon health during the fourth quarter worth about $51,000.

Analyst Ratings Changes

A number of research firms have recently weighed in on AGL. Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and increased their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They set a "neutral" rating and a $3.00 price target on the stock. Sanford C. Bernstein upped their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada upped their price target on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $3.95.

Remove Ads

agilon health Stock Up 1.7 %

Shares of agilon health stock traded up $0.08 during midday trading on Thursday, hitting $4.60. The company had a trading volume of 3,152,704 shares, compared to its average volume of 4,599,551. agilon health, inc. has a 52-week low of $1.50 and a 52-week high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $1.89 billion, a P/E ratio of -4.89 and a beta of 0.67. The company has a 50 day moving average of $3.61 and a 200 day moving average of $2.96.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.